General Information of Drug Off-Target (DOT) (ID: OT04YLXE)

DOT Name Torsin-3A (TOR3A)
Synonyms ATP-dependent interferon-responsive protein; Torsin family 3 member A
Gene Name TOR3A
Related Disease
Autism spectrum disorder ( )
Autism ( )
Intellectual disability ( )
UniProt ID
TOR3A_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF21376 ; PF06309
Sequence
MLRGPWRQLWLFFLLLLPGAPEPRGASRPWEGTDEPGSAWAWPGFQRLQEQLRAAGALSK
RYWTLFSCQVWPDDCDEDEEAATGPLGWRLPLLGQRYLDLLTTWYCSFKDCCPRGDCRIS
NNFTGLEWDLNVRLHGQHLVQQLVLRTVRGYLETPQPEKALALSFHGWSGTGKNFVARML
VENLYRDGLMSDCVRMFIATFHFPHPKYVDLYKEQLMSQIRETQQLCHQTLFIFDEAEKL
HPGLLEVLGPHLERRAPEGHRAESPWTIFLFLSNLRGDIINEVVLKLLKAGWSREEITME
HLEPHLQAEIVETIDNGFGHSRLVKENLIDYFIPFLPLEYRHVRLCARDAFLSQELLYKE
ETLDEIAQMMVYVPKEEQLFSSQGCKSISQRINYFLS
Tissue Specificity Ubiquitously expressed. Highest expression in stomach, salivary glands and lymph nodes. Isoform 2 is expressed in placenta.

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Autism spectrum disorder DISXK8NV Strong Biomarker [1]
Autism DISV4V1Z Disputed Biomarker [2]
Intellectual disability DISMBNXP Disputed Biomarker [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Torsin-3A (TOR3A). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Torsin-3A (TOR3A). [14]
------------------------------------------------------------------------------------
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Torsin-3A (TOR3A). [4]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Torsin-3A (TOR3A). [5]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Torsin-3A (TOR3A). [6]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Torsin-3A (TOR3A). [7]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Torsin-3A (TOR3A). [8]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Torsin-3A (TOR3A). [9]
Testosterone enanthate DMB6871 Approved Testosterone enanthate affects the expression of Torsin-3A (TOR3A). [10]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Torsin-3A (TOR3A). [11]
Nabiximols DMHKJ5I Phase 3 Nabiximols increases the expression of Torsin-3A (TOR3A). [12]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of Torsin-3A (TOR3A). [13]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Torsin-3A (TOR3A). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)

References

1 Frequency of risk factors and coexisting abnormalities in a population of Egyptian children with autism spectrum disorder.Asian J Psychiatr. 2018 Feb;32:54-58. doi: 10.1016/j.ajp.2017.11.037. Epub 2017 Dec 1.
2 Some children with autism have latent social skills that can be tested.Neuropsychiatr Dis Treat. 2017 Mar 16;13:827-833. doi: 10.2147/NDT.S131661. eCollection 2017.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
5 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
6 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
7 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
8 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
9 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
10 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
11 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
12 Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.
13 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
15 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.